Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for m root_references_citation in Reference Text / Citation (approximate match)

Showing 201 - 210 of 1136 results

First page
Previous page
Next page
Next page

(2α)-17-(Acetyloxy)-2-hydroxy-6-methyl-19-norpregna-4,6-diene-3,20-dione

ET63GCG8TP

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

(2α)-17-(Acetyloxy)-2-glucoronide-6-methyl-19-norpregna-4,6-diene-3,20-dione

YLK5RSH57K

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

Normethoxetamine

6MY8JHU7ED

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (RACEMIC)

4-Chloroaspartame

CRZ8G23LT9

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

TAS-303

A6XE99NLS9

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

Lacto-N-fucopentaose III

JRK5FGA8LX

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

MRTX-1133

DU32DM9CHD

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (MIXED)

SLC-0111

ANM9DBL9JT

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Carbonic anhydrase IX

Carbonic anhydrase XII

Carbonic anhydrase II

Carbonic anhydrase I

Conditions:

U-104 is an inhibitor of CA IX that binds only to CA IX under hypoxic conditions in vivo. The binding results in significant inhibition of tumor growth and metastasis formation in both spontaneous and experimental models of metastasis. U-104 reduces the medium acidity by inhibiting the catalytic activity of the CA IX. It binds specifically only to hypoxic cells expressing CA IX.

7-methyl(3'-O-methyl)GpppGP cap

427EK6X4GY

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (EPIMERIC)

T-401 F-18

ZG3YL7RN5R

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

Structure of (2α)-17-(Acetyloxy)-2-hydroxy-6-methyl-19-norpregna-4,6-diene-3,20-dione

ABSOLUTE

(2α)-17-(Acetyloxy)-2-hydroxy-6-methyl-19-norpregna-4,6-diene-3,20-dione

Structure of (2α)-17-(Acetyloxy)-2-glucoronide-6-methyl-19-norpregna-4,6-diene-3,20-dione

ABSOLUTE

(2α)-17-(Acetyloxy)-2-glucoronide-6-methyl-19-norpregna-4,6-diene-3,20-dione

Structure of Normethoxetamine

RACEMIC

Normethoxetamine

Structure of 4-Chloroaspartame

ABSOLUTE

4-Chloroaspartame

Structure of TAS-303

ACHIRAL

Structure of Lacto-N-fucopentaose III

ABSOLUTE

Lacto-N-fucopentaose III

Structure of MRTX-1133

MIXED

Structure of SLC-0111

ACHIRAL

Structure of 7-methyl(3'-O-methyl)GpppGP cap

EPIMERIC

7-methyl(3'-O-methyl)GpppGP cap

Structure of T-401 F-18

ABSOLUTE

Showing 201 - 210 of 1136 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1